President Trump announced in the statement that White House senior staff would get the vaccine at a later stage of the roll-out and that essential workers would be placed at the front of the line at this time.

With a sharp increase in valuations and profits due to the pandemic, the food delivery startup will debut as of one of the highest profile IPOs this year, expecting to sell 33 million shares.

News of a vaccine sent the US financial markets soaring this week and there’s real hope that maybe we may have taken a giant step in dealing with the virus once and for all.

The company has seen its value grow by a whopping 431% since its Initial Public Offering. As a result, CureVac was able to get up to $231 million in initial funding, which is expected to go towards research and development.

The well-known drug now comes at an inhalable form that has shown promise in combating the Coronavirus pandemic.

After clamors to reopen shutdown economies around the world continue to grow, World Health Organization head noted that “the worst is yet ahead of us” and cautioned that there’s still a lot we don’t know about the virus